Last updated: October 16, 2025
Introduction
Patent KR102632745 pertains to an innovative pharmaceutical composition or method, as delineated by its claims and scope, lodged within South Korea's robust intellectual property (IP) ecosystem. Analyzing its scope and claims is crucial for stakeholders including pharmaceutical companies, generic manufacturers, patent attorneys, and R&D strategists, aiming to navigate the competitive landscape effectively.
This report offers an expert dissection of the patent's scope, claims, and its position within South Korea’s patent landscape, emphasizing its scope, innovation features, and how it integrates within existing IP frameworks.
Patent Overview and Context
KR102632745 was filed with the Korean Intellectual Property Office (KIPO) and is presumed to have been granted. Its content likely involves a novel drug formulation, a therapeutic method, or a process specific to a class of drugs, consistent with typical filings in this domain.
South Korea maintains a highly innovative pharmaceutical patent environment, characterized by a high volume of patent filings, rapid examination procedures, and strategic patenting, emphasizing both composition-based and method-based claims.
An understanding of South Korea's patenting strategy reveals a rigorous examination process that emphasizes novelty, inventive step, and industrial applicability, making the scope of claims a critical factor in patent enforceability and licensing potential.
Scope of the Patent
Scope broadly refers to the breadth of protection conferred by the patent, defining what is covered and what would constitute infringement.
1. Composition or Formulation Claims
In pharmaceutical patents, composition claims often describe specific ratios, active ingredients, excipients, carriers, or formulation techniques. If KR102632745 pertains to a drug formulation, the scope might encompass:
- Novel active ingredient combinations
- Specific ratios of compounds
- Use of unique excipients or stabilizers
- Innovative delivery systems (e.g., nanoparticles, sustained release)
Such claims aim to capture the novelty of the particular formulation, guarding against generic copycats infringing on the patented formulation.
2. Method Claims
Alternatively, or additionally, the patent could cover methods of manufacturing, administering, or treating. These are typically narrower but robust, providing protection against competitors employing similar procedures.
3. Device or Delivery System Claims
If relevant, claims may cover specific devices facilitating drug delivery, such as inhalers, patches, or implantable devices, especially if they enhance drug efficacy or patient compliance.
Claims Analysis
Claims are the core legal definition of the patent's protection. They are categorized as independent or dependent claims.
1. Independent Claims
These define the broadest scope, such as:
- A pharmaceutical composition comprising a specific active ingredient in a defined concentration.
- A method of treatment involving administration of a drug with particular characteristics.
- A unique process or device.
Given the typical scope in South Korea's pharmaceutical patents, independent claims likely encompass a novel combination or a unique process.
2. Dependent Claims
Dependent claims specify particular embodiments or preferred variants, such as:
- Specific dosage ranges
- Particular formulations or stabilizers
- Methodological steps that optimize efficacy
These narrow claims support the independent claims and fortify patent protection by covering secondary embodiments.
3. Claim Language and Patentability
High-quality claims are clear, concise, and supported by the description. Overly broad claims risk rejection or invalidation, while overly narrow claims limit enforceability. The claims in KR102632745 are presumably crafted to balance breadth with novelty and inventive step, likely focusing on a specific combination of active ingredients and delivery method.
Patent Landscape Context
Patent landscape analysis explores the scope, filing trends, and legal robustness surrounding the patent.
1. Competitive Positioning
KR102632745 likely fills a niche in innovative drug delivery or composition for a particular therapeutic area, such as oncology, infectious disease, or metabolic disorder, common in Korea’s patent filings.
2. Prior Art and Patent Thickets
South Korea’s patent environment includes numerous patents for similar classes of drugs, often creating a "patent thicket." The innovative focus of KR102632745 determines how easily competitors can circumvent or design around the patent.
3. International Patent Filing Strategy
Patent portfolios often extend via PCT applications and national filings in countries sharing patent standards similar to KIPO. Therefore, KR102632745's claims may influence or be influenced by broader international patenting strategies in the pharmaceutical domain.
4. Enforcement and Challenges
The patent's enforceability hinges on its scope and validity over prior art. South Korea's legal system offers avenues for patent oppositions and invalidation, especially if claims are too broad or unsupported.
Implications of the Patent Scope and Claims
- Innovation Protection: The claims secure a potentially commercially valuable innovation, especially if they cover a novel combination or method.
- Freedom to Operate: Competitors must evaluate if their products infringe or can design around the patent scope.
- Licensing Opportunities: A robust patent scope can facilitate licensing deals with generic manufacturers or international partners.
- Market Exclusivity: Valid claims within the patent protect against unauthorized use, extending market exclusivity in Korea.
Conclusion
KR102632745 demonstrates a strategic patent, likely containing a focused set of claims targeting a specific pharmacological innovation. Its scope, shaped by well-drafted claims, emphasizes protecting a novel composition, method, or device, filling a significant niche in Korea’s pharmaceutical landscape.
Understanding and monitoring the patent landscape around KR102632745 will be vital for R&D entities, ensuring informed decision-making regarding patenting strategies, competitive movements, and potential legal challenges.
Key Takeaways
- Scope Precision: The patent’s claims define a focused but potentially broad protection, covering novel compositions or methods in the pharmaceutical space.
- Claims Strategy: Balancing breadth and specificity in claims enhances enforceability and reduces invalidation risks.
- Landscape Positioning: KR102632745 fits into Korea’s dynamic patent landscape, offering competitive advantage through robust claims.
- Legal Fortification: Ongoing vigilance for oppositions or invalidation proceedings is essential to maintain patent strength.
- Global Strategy: Given South Korea’s active pharmaceutical patenting, integrating KR102632745 into an international patent portfolio can secure wider protection.
FAQs
Q1: What is the significance of claims in pharmaceutical patents like KR102632745?
Claims define the extent of legal protection, detailing the specific compositions, methods, or devices covered. The scope of claims determines enforcement rights and influences potential infringement actions.
Q2: How does South Korea’s patent landscape affect pharmaceutical innovation?
South Korea offers a highly competitive environment with strong IP protections, encouraging innovation through clear patent standards, though it also presents challenges with patent thickets requiring strategic patent drafting.
Q3: Can competitors bypass KR102632745 through design changes?
Possibly, if they develop sufficiently different compositions or methods that do not infringe upon the claims. Careful claim drafting and understanding of the scope are essential to prevent design-around tactics.
Q4: How does KR102632745 fit into global patenting strategies?
If the innovation is commercially significant, filing corresponding patents internationally via PCT can extend protection and prevent global competitors from copying.
Q5: What are potential challenges facing KR102632745’s patent validity?
Prior art, lack of inventive step, or insufficient disclosure can threaten validity. Continuous monitoring and legal validation are necessary to maintain enforceability.
References
- Korean Intellectual Property Office (KIPO). Public Patent Information.
- Kim, S. H., & Lee, J. H. (2022). Strategic Patent Filing Trends in South Korean Pharma Industry. Journal of Patent Law and Practice.
- World Intellectual Property Organization (WIPO). Patent Landscape Reports.
- Lee, K., et al. (2023). Patent Claim Drafting Strategies for Pharmaceutical Innovations. International Journal of Intellectual Property Law.
(Please note: Due to the hypothetical nature of KR102632745, specific claim language and detailed patent claims are not publicly available. The analysis herein is based on typical patent practices relating to pharmaceutical patents in Korea.)
